Suppr超能文献

综述论文:壳聚糖衍生物作为可控药物递送的有前景材料

Review paper: chitosan derivatives as promising materials for controlled drug delivery.

作者信息

Prabaharan Mani

机构信息

Department of Mechanical Engineering University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA.

出版信息

J Biomater Appl. 2008 Jul;23(1):5-36. doi: 10.1177/0885328208091562.

Abstract

Chitosan, a natural based-polymer obtained by alkaline deacetylation of chitin, is nontoxic, biocompatible, and biodegradable. These properties make chitosan a good candidate for the development of conventional and novel drug delivery systems. Chitosan has been found to be used as a support material for gene delivery, cell culture, and tissue engineering. However, practical use of chitosan has been mainly confined to the unmodified forms. For a breakthrough in utilization, especially in the field of controlled drug delivery, graft copolymerization onto chitosan will be a key point, which will introduce desired properties and enlarge the field of the potential applications of chitosan by choosing various types of side chains. Chemical modification of chitosan is useful for the association of bioactive molecules to polymer and controlling the drug release profile. This paper reviews the various methods of preparation of chitosan derivatives intended for controlled drug delivery. From the studies reviewed it is concluded that chitosan derivatives are promising materials for controlled drug and nonviral gene delivery.

摘要

壳聚糖是一种通过甲壳素碱性脱乙酰作用得到的天然聚合物,无毒、具有生物相容性且可生物降解。这些特性使壳聚糖成为开发传统和新型药物递送系统的理想候选材料。壳聚糖已被用作基因递送、细胞培养和组织工程的载体材料。然而,壳聚糖的实际应用主要局限于未改性形式。为了在应用方面取得突破,特别是在控释药物领域,壳聚糖的接枝共聚将是关键,通过选择各种类型的侧链可以引入所需特性并扩大壳聚糖的潜在应用领域。壳聚糖的化学改性有助于生物活性分子与聚合物结合并控制药物释放曲线。本文综述了用于控释药物的壳聚糖衍生物的各种制备方法。从所综述的研究可以得出结论,壳聚糖衍生物是用于控释药物和非病毒基因递送的有前景的材料。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验